European regulators approve Amgen cancer drug Kyprolis
Health Care & Life Science, Latest news, TechnologyThousand Oaks-based Amgen scored another major victory Nov. 19. European regulators approved experimental drug Kyprolis on Thursday for patients who have received at least one prior treatment for multiple-myeloma. Kyprolis was the cornerstone of Amgen’s $10.4 billion buyout of Onyx Pharmaceuticals in 2013. Multiple-myeloma is a form of blood cancer that forms in plasma cells Read More →
Semtech third quarter earnings per share miss estimate
Earnings, Latest news, Tri-County Public CompaniesSemtech, a Camarillo-based maker of semiconductors for cell phones and electronic devices, missed analyst estimates slightly when the company reported third quarter results Nov. 18. Semtech reported earnings per share of 16 cents. Analysts had expected earnings per share of 24 cents. Semtech slightly exceeded analyst revenue estimates of $115.4 million by posting earnings of Read More →
French Hospital Medical Center unveils educational facility
Central Coast, Health Care & Life Science, Latest news, Top StoriesFrench Hospital Medical Center has taken the wraps off an 18,000-square-foot health and education facility it hopes will forge closer ties between the hospital and higher education in San Luis Obispo. With about 200 business and community leaders standing by, CEO Alan Iftinik unveiled the Copeland Health Education Pavilion. Iftinik said the building, which Read More →
Inogen’s third quarter earnings beat Wall Street expectations
Earnings, Health Care & Life Science, Latest news, Top Stories, Tri-County Public CompaniesInogen, a Goleta-based maker of direct-to-consumer respiratory products, beat analyst estimates for revenue when the company released third quarter earnings on Nov. 10. Revenues were up 38.7 percent from $29.4 million during the third quarter of last year to $40.8 million this year. Analysts had predicted revenues of $37 million. Inogen also reported adjusted Read More →
